Entera Bio (ENTX) Current Deferred Revenue (2018 - 2021)
Entera Bio's (ENTX) quarterly Current Deferred Revenue came in at $15000.0 in Q4 2021, down 90.51% YoY from $158000.0 in Q4 2020, and up 87.5% on a QoQ basis from $8000.0 in Q2 2021.
Entera Bio (ENTX) Current Deferred Revenue (2018 - 2021) Analysis & Trends
Entera Bio (ENTX) has 4 years of Current Deferred Revenue data on file, last reported at $15000.0 in Q4 2021.
- Quarterly Current Deferred Revenue fell 90.51% year-over-year to $15000.0 in Q4 2021, while the trailing twelve-month figure through Dec 2021 was $15000.0 (down 90.51% YoY) and the FY2021 annual result came in at $15000.0, down 90.51% from the prior year.
- Current Deferred Revenue rose to $15000.0 in Q4 2021, from $8000.0 in the prior quarter.
- In the past five years, Current Deferred Revenue ranged from a high of $267000.0 in Q4 2019 to a low of $8000.0 in Q2 2021.
- A 4-year average of $141000.0 and a median of $165500.0 in 2020 frame the typical range for Current Deferred Revenue.
- Annual changes were most pronounced in 2019 — Current Deferred Revenue climbed 18.67% — and 2021, when it slumped 95.38%.
- Tracing ENTX's Current Deferred Revenue over 4 years: stood at $225000.0 in 2018, then gained by 18.67% to $267000.0 in 2019, then sank by 40.82% to $158000.0 in 2020, then slumped by 90.51% to $15000.0 in 2021.
- The last three Current Deferred Revenue figures came in at $15000.0 (Q4 2021), $8000.0 (Q2 2021), and $158000.0 (Q4 2020), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.90 Bn | 131.05 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.10 Bn | 78.11 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.56 Bn | 60.37 Bn | 1.37 Bn |
| 4 | Moderna | 55.82 Bn | 50.68 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.14 Bn | 37.04 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.67 Bn | 28.36 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.74 Bn | 9.35 Bn | 668.28 Mn |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.38 Bn | 26.54 Bn | - |
| 10 | Entera Bio | 163.97 Mn | 152.66 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | 15,000.00 |
| Jun 30, 2021 | 8,000.00 |
| Dec 31, 2020 | 158,000.00 |
| Jun 30, 2020 | 173,000.00 |
| Dec 31, 2019 | 267,000.00 |
| Dec 31, 2018 | 225,000.00 |